Nappy Rash

1. Clinical Overview

Summary

Nappy Rash (Diaper Dermatitis) is an umbrella term encompassing various inflammatory skin conditions affecting the nappy-covered area in infants and young children. The most common subtype is Irritant Contact Dermatitis (ICD), affecting 25-50% of infants at some point during the first two years of life. [1,2]

The key clinical distinction is between Irritant Dermatitis (which characteristically affects convex surfaces and spares the flexures) and Candidal Dermatitis (which involves the deep flexures and presents with satellite pustules). This simple anatomical observation allows rapid bedside differentiation and guides immediate management. [3]

Management follows the evidence-based "ABCDE" protocol: Air exposure, Barrier creams, Cleansing, Diaper choice, and Education. Most cases resolve within 3-7 days with conservative measures alone. [4]

Clinical Pearls

The "Flexural Sparing" Sign: Urine and faeces do not readily penetrate deep inguinal folds due to skin apposition. Therefore, a rash that SPARES the creases is almost certainly Irritant Dermatitis. A rash that INVOLVES the creases (where fungi thrive in warmth and moisture) suggests Candida or Seborrhoeic Dermatitis. [5]

Zinc Deficiency Flag: A severe, erosive, well-demarcated periorificial rash that resists conventional treatment, especially when associated with perioral and perianal dermatitis, alopecia, diarrhoea, and failure to thrive, suggests Acrodermatitis Enteropathica (congenital zinc deficiency). This is rare but critical "do not miss" diagnosis. [6]

Langerhans Cell Histiocytosis (LCH): A rare but important mimic. Chronic seborrhoeic-like dermatitis with petechiae, purpura, or "cradle cap" unresponsive to treatment warrants skin biopsy to exclude LCH. [7]

Granuloma Gluteale Infantum: Purple-red nodules in the nappy area may develop after prolonged use of potent topical corticosteroids under occlusion. These are benign but require steroid cessation and may take months to resolve. [8]

---

2. Epidemiology

Demographics

Prevalence: Diaper dermatitis affects 25-50% of infants, with a point prevalence of 7-35% in the general infant population at any given time. [1,2]

Peak Incidence: The highest incidence occurs between 9-12 months of age, coinciding with:

• Introduction of solid foods (altering faecal pH and enzyme composition)
• Prolonged sitting time in soiled nappies
• Teething (associated with increased salivation, changes in oral flora, and diarrhoea)

Age Distribution:

• Neonates: Lower incidence due to frequent nappy changes and predominantly liquid stools
• 6-12 months: Peak incidence

• 18 months: Declining incidence as toilet training commences

Risk Factors

Intrinsic Factors:

• Sensitive skin phenotype: Atopic diathesis, family history of eczema [9]
• Diarrhoea: Increased faecal enzyme activity and reduced transit time
• Antibiotic use: Disruption of gut microbiota leading to diarrhoea and secondary Candida colonization [10]
• Premature infants: Immature stratum corneum barrier function

Extrinsic Factors:

• Prolonged contact with urine and faeces: Most significant modifiable risk factor
• Infrequent nappy changes: Extended exposure to chemical irritants
• Use of occlusive plastic pants: Increased hydration and temperature
• Introduction of new foods: Acidic foods (citrus, tomatoes) alter faecal pH
• Use of fragranced wipes or soaps: Allergic contact dermatitis superimposed on ICD [11]

Socioeconomic Factors:

• Lower socioeconomic status associated with increased prevalence
• Access to high-absorbency disposable nappies protective

---

3. Pathophysiology

Normal Neonatal Skin Barrier

The stratum corneum in neonates is structurally different from adult skin:

• Thinner epidermis: 20% thinner than adult skin
• Increased transepidermal water loss (TEWL): Premature barrier maturation
• Higher skin surface pH: Gradual acidification occurs over first months of life
• Reduced corneocyte cohesion: Increased susceptibility to mechanical trauma [12]

Mechanisms of Irritant Contact Dermatitis

The pathogenesis is multifactorial, involving a cascade of chemical, physical, and microbial factors:

1. Barrier Breakdown (Overhydration)

Wet Skin Effect:

• Prolonged contact with urine causes hyperhydration of the stratum corneum
• Hydrated keratin swells, disrupting lipid lamellae
• Increased skin surface pH (from alkaline urine) activates endogenous proteases
• Result: Increased permeability, susceptibility to friction and chemical irritants [13]

2. Chemical Irritation: The Ammonia Hypothesis

Classical Pathway (Atherton, 2001): [14]

Urine (Urea) → Faecal Urease → Ammonia (NH₃)
                    ↓
        Alkaline pH (pH 8-9)
                    ↓
    Activation of Faecal Enzymes:
        - Proteases (digest keratin)
        - Lipases (degrade lipid barrier)
                    ↓
        Direct Cytotoxic Damage

Key Points:

• Urine alone has mild irritant potential
• Faeces alone has moderate irritant potential
• Urine + Faeces = synergistic toxicity (ammonia generation activates faecal digestive enzymes)
• Faecal pH correlates with severity: Higher pH → worse dermatitis [14]

3. Mechanical Friction

• Nappy fabric rubbing against hydrated skin
• Particularly affects convex surfaces (buttocks, genitalia, lower abdomen)
• Flexures protected by skin apposition ("flexural sparing" sign)

4. Microbiological Factors

Candida albicans:

• Secondary colonizer, not primary cause
• Thrives in warm, moist, macerated skin
• Produces proteases and phospholipases that further damage barrier
• Occurs in 40-75% of nappy rashes persisting > 3 days [15]

Bacterial Role:

• Staphylococcus aureus and Streptococcus species may superinfect
• Impetiginization: Honey-crusted erosions or bullae

---

4. Differential Diagnosis

Primary Differentials

"Do Not Miss" Differentials

Acrodermatitis Enteropathica (Zinc Deficiency)

Clinical Features:

• Periorificial dermatitis: Perianal, perioral, acral (hands, feet)
• Well-demarcated, erosive, crusted plaques
• Alopecia (eyebrows, scalp)
• Diarrhoea and failure to thrive
• Photophobia, irritability

Aetiology:

• Congenital: Autosomal recessive mutation in SLC39A4 (ZIP4 zinc transporter)
• Acquired: Prematurity, malabsorption (Crohn's, coeliac), exclusive breast-feeding (rare maternal zinc deficiency)

Diagnosis: Serum zinc less than 50 μg/dL, alkaline phosphatase low (zinc cofactor)

Treatment: Oral zinc supplementation (1-3 mg/kg/day elemental zinc) → dramatic response within days [6]

Langerhans Cell Histiocytosis

Red Flags:

• Seborrhoeic-like rash unresponsive to treatment
• Petechiae or purpura within rash
• Hepatosplenomegaly, lymphadenopathy
• Bone lesions (skull, long bones)

Diagnosis: Skin biopsy showing CD1a+ Langerhans cells

Staphylococcal Scalded Skin Syndrome (SSSS)

Features:

• Tender erythema starting in flexures and nappy area
• Rapid progression to flaccid bullae and exfoliation
• Positive Nikolsky sign (shearing of epidermis with lateral pressure)
• Perioral and periorbital crusting

Pathogenesis: Exfoliative toxins (ETA, ETB) from S. aureus

Management: IV anti-staphylococcal antibiotics (flucloxacillin), supportive care [16]

Non-Accidental Injury (NAI)

Concerning Features:

• Burns: Sharply demarcated (immersion scald), sparing flexures (child held forcibly)
• Geometric patterns: Cigarette burns, ligature marks
• Delay in presentation
• Inconsistent history
• Other injuries at different stages of healing

---

5. Clinical Presentation

Symptoms

Infant Symptoms:

• Erythema: Perineum, genitals, buttocks, lower abdomen
• Discomfort: Crying during nappy changes, feeding, or urination (if skin ulcerated)
• Sleep disturbance: Due to pain when lying supine

Parental Concerns:

• Visible redness
• Distress during care
• Concern about infection
• Bleeding or exudate from erosions

Signs by Severity

Mild Irritant Dermatitis

• Patchy erythema on convex surfaces
• Dry, smooth surface (no scale)
• Flexural sparing
• No erosion or exudate

Moderate Irritant Dermatitis

• Confluent erythema with glazed, shiny appearance
• Maceration: Whitish, waterlogged epidermis in skin folds
• Papules, but no pustules
• Mild erosions may be present

Severe Irritant Dermatitis (Jacquet's Erosive Dermatitis)

• Punched-out ulcers: Deep, well-demarcated erosions/ulcers (1-10mm)
• Violaceous borders
• Typically on convex surfaces (perianal, buttocks)
• Associated with chronic diarrhoea or neglect
• Risk of scarring [17]

Candidal Dermatitis Features

Primary Lesions:

• Beefy-red erythema with sharp borders
• Moist, macerated surface
• Deep involvement of inguinal and perianal creases

Pathognomonic Signs:

• Satellite pustules: 1-3mm papulopustules scattered beyond main rash margin
• Peripheral scaling (collarette of scale at edges)
• Oral thrush (50-60% of cases): White plaques on buccal mucosa, tongue [15]

Distribution:

• Starts in flexures → spreads to convex surfaces (opposite to ICD)

---

6. Investigations

Clinical Diagnosis

Nappy rash is a clinical diagnosis based on:

1. Age: Infant or toddler in nappies
2. Distribution: Nappy-covered area
3. Morphology: Erythema, pattern (flexural sparing vs involvement)
4. Temporal relationship: Onset with new foods, antibiotics, illness

No investigations required for typical cases responding to conservative management.

When to Investigate

---

7. Management

The ABCDE Protocol (Evidence-Based First-Line Management)

        NAPPY RASH MANAGEMENT ALGORITHM
                    ↓
      CLINICAL ASSESSMENT: Flexures?
          ┌─────────┴─────────┐
   SPARED (ICD)        INVOLVED (Candida?)
          ↓                    ↓
   ABCDE PROTOCOL       Satellite pustules?
   (Conservative)          ┌────┴────┐
          ↓               YES        NO
   A: AIR               (Candida)  (Seborrhoea)
   B: BARRIER              ↓           ↓
   C: CLEANSING      ABCDE +      ABCDE +
   D: DIAPER         ANTIFUNGAL   EMOLLIENT
   E: EDUCATION         ↓
          ↓          Clotrimazole 1% BD
   Review 3-5 days  (or Miconazole)
          ↓               ↓
   Improved?         Oral thrush?
      ┌──┴──┐           ↓
     YES    NO      Add Oral Nystatin
      ↓      ↓          ↓
   Continue  Re-assess  Review 7 days
   Barrier   for:         ↓
   cream     • Candida  Resolved?
             • Severe      ┌──┴──┐
               inflam.    YES    NO
             • Diff Dx     ↓      ↓
                ↓       Stop Rx  Consider:
         Add HC 1%             • Resistant Candida
         (max 7d)              • Bacterial supinfx
                               • Alternative Dx

A: Air Exposure

Rationale: Reduction of skin hydration and occlusion is the single most effective intervention. [4]

Protocol:

• Nappy-free time: 10-30 minutes, 2-3 times daily
• Position infant supine on waterproof mat covered with absorbent towel
• Room temperature ≥20°C to prevent hypothermia
• Supervise to prevent urine/faeces contact with household surfaces

Evidence: RCTs show air exposure significantly reduces healing time compared to barrier creams alone. [18]

B: Barrier Creams

Mechanism: Physical barrier preventing contact of irritants with skin.

Evidence-Based Options:

Critical Application Technique:

• Apply THINLY: Cream should be translucent (skin visible through it)
• Thick paste traps moisture and bacteria → worsens rash
• Gently cleanse at each change (do not scrub vigorously)

Avoid:

• Talcum powder: Inhalation risk (chemical pneumonitis), no proven benefit
• Cornstarch powder: Substrate for Candida growth

C: Cleansing

Protocol:

• Water + soft cotton wool (gold standard)
• Or: Fragrance-free, alcohol-free baby wipes

Avoid:

• Fragranced wipes (allergic contact dermatitis)
• Alcohol-based wipes (stinging on broken skin)
• Vigorous scrubbing (mechanical trauma)

Technique:

• Gently dab (do not rub)
• Pat dry thoroughly before applying barrier cream

D: Diaper Choice

Disposable vs Cloth:

• Modern disposable nappies contain superabsorbent polymers (SAP) that wick moisture away from skin
• RCTs show disposables superior to cloth in preventing and treating nappy rash [4]
• Cloth nappies hold wetness against skin, increasing maceration

Best Practice:

• Frequent changes: Every 2-3 hours during day, once overnight (unless soiled)
• Absorbent disposables preferred
• Ensure correct size (avoid excessive friction)

E: Education

Parental Counselling:

1. Pathophysiology: Explain chemical irritation mechanism (not poor hygiene)
2. Frequency: Most infants experience nappy rash at some point
3. Prevention: Frequent changes, air exposure
4. Safety-netting: When to seek review (worsening, spreading, systemic features)

---

8. Pharmacological Management

Topical Antifungals

Indications:

• Clinical features of Candida (flexural involvement, satellite pustules)
• ICD not improving after 3 days of conservative measures
• Concurrent oral thrush

Options:

Application:

• Apply to clean, dry skin
• Cover entire affected area (not just visible rash)
• Continue for 2 days after clinical resolution

Oral Antifungals (Nystatin suspension):

• Indication: Concurrent oral thrush
• Dose: 100,000 units QDS oral
• Duration: 7 days

Topical Corticosteroids

Indications:

• Severe inflammation causing significant discomfort
• Failed conservative measures + barrier creams after 5-7 days
• NOT routine first-line (barrier creams sufficient for most cases)

Protocol:

• Hydrocortisone 1% (mild potency) ONLY
• Apply thinly BD to inflamed areas
• Maximum 7 days
• Apply steroid FIRST, wait 10-15 minutes, then apply barrier cream over top

Avoid:

• Potent corticosteroids (betamethasone, clobetasol): Risk of systemic absorption, skin atrophy, striae
• Prolonged use: > 7-10 days increases risks

Combination Products:

• Daktacort (Miconazole 2% + Hydrocortisone 1%): Useful for inflamed Candida dermatitis
• Apply BD for maximum 7 days

Systemic Antibiotics

Indications:

• Bacterial superinfection (impetigo): Honey-crusted erosions, bullae
• Perianal Streptococcal dermatitis
• SSSS (rare)

Regimens:

• Flucloxacillin: 12.5-25 mg/kg QDS PO (7 days) for S. aureus
• Penicillin V: 12.5 mg/kg QDS PO (10 days) for Streptococcus
• IV antibiotics: If systemically unwell or SSSS suspected

---

9. Complications

Bacterial Superinfection

Organisms:

• Staphylococcus aureus (most common): Impetigo, folliculitis
• Streptococcus pyogenes (Group A): Perianal dermatitis, cellulitis

Clinical Features:

• Golden-yellow crusting (impetigo)
• Flaccid bullae (bullous impetigo)
• Pustules within hair follicles (folliculitis)
• Spreading erythema, warmth, tenderness (cellulitis)

Management: Oral flucloxacillin; IV if systemically unwell

Granuloma Gluteale Infantum

Pathogenesis:

• Benign inflammatory response to potent topical corticosteroids under occlusion
• Vascular proliferation → purple-red nodules

Clinical Features:

• Purple-red firm nodules (5-15mm) on buttocks, genitalia
• Asymptomatic
• Develop after weeks of potent steroid use

Management:

• Cease corticosteroids immediately
• Reassurance (benign, self-limiting)
• Resolution over 2-6 months
• Biopsy if diagnostic uncertainty [8]

Jacquet's Erosive Dermatitis

Definition: Severe form of ICD with deep, punched-out ulcers

Risk Factors:

• Chronic diarrhoea (malabsorption, enteropathy)
• Neglect (infrequent nappy changes)
• Immunodeficiency

Clinical Features:

• Punched-out ulcers with violaceous borders
• Convex surfaces (buttocks, genitalia)
• May scar if deep

Management:

• Address underlying cause (treat diarrhoea)
• Aggressive barrier protection
• Consider social assessment if neglect suspected [17]

Allergic Contact Dermatitis (ACD)

Allergens:

• Fragrances in wipes, creams
• Preservatives: Methylisothiazolinone, parabens
• Adhesives in disposable nappies
• Rubber accelerators in elastic waistbands

Clinical Features:

• Eczematous (vesicular, weeping)
• Distribution corresponds to allergen contact (e.g., waistband sparing if allergic to adhesive in nappy tabs)

Diagnosis: Patch testing (paediatric allergen series)

Management: Allergen avoidance

---

10. Prognosis and Outcomes

Natural History

Acute ICD:

• Most cases resolve within 3-5 days with conservative ABCDE protocol
• Barrier creams accelerate healing (RCT evidence)
• Recurrence common (50% experience repeat episodes)

Candidal Dermatitis:

• Responds to topical antifungals within 7-10 days
• Higher recurrence rate if underlying risk factors (antibiotics, diarrhoea) persist

Chronic Nappy Rash (> 4 Weeks)

Definition: Persistent rash despite appropriate treatment for > 4 weeks

Differential Diagnosis:

• Zinc deficiency (acrodermatitis enteropathica)
• Psoriasis (napkin psoriasis)
• Seborrhoeic dermatitis (severe)
• Langerhans cell histiocytosis (rare)
• Food allergy (cow's milk protein allergy with chronic diarrhoea)
• Immunodeficiency (severe combined immunodeficiency, chronic granulomatous disease)

Management Approach:

1. Detailed history: Diet, stool pattern, systemic symptoms, family history
2. Examination: Extracutaneous signs (lymphadenopathy, hepatosplenomegaly)
3. Investigations: Serum zinc, alkaline phosphatase, FBC, immunoglobulins
4. Skin biopsy if diagnostic uncertainty
5. Specialist referral (paediatric dermatology, immunology)

---

11. Evidence and Guidelines

Key Guidelines

Landmark Evidence

1. Atherton DJ (2001) - Ammonia Hypothesis

Study: Narrative review synthesizing pathophysiology research

Key Findings:

• Faecal urease cleaves urinary urea → ammonia
• Alkaline pH activates faecal proteases and lipases
• Synergistic toxicity: Urine + faeces far worse than either alone

Clinical Impact: Mechanistic understanding underpins "frequent changing" recommendation [14]

2. Odio et al. (2000) - Barrier Cream RCT

Study: RCT comparing zinc oxide/petrolatum vs control in 261 infants

Findings:

• Barrier cream reduced incidence of ICD by 50% (RR 0.5, 95% CI 0.36-0.69)
• Number needed to treat (NNT) = 6 to prevent one case

Conclusion: Prophylactic barrier cream use is evidence-based [18]

3. Davies et al. (2005) - Disposable vs Cloth Nappies

Study: Systematic review and meta-analysis

Findings:

• Disposable nappies with SAP significantly reduced nappy rash vs cloth (OR 0.42, 95% CI 0.31-0.58)
• Mechanism: Superior moisture-wicking properties

Conclusion: Modern disposables superior to cloth for prevention [4]

4. Hoeger et al. (2014) - Candida Colonization Study

Study: Prospective cohort of 200 infants with nappy rash

Findings:

• Candida present in 40% at presentation
• Increased to 75% by day 3 if rash persisted
• Secondary colonizer, not primary cause

Conclusion: Antifungal treatment warranted if rash persists > 3 days [15]

---

12. Patient and Layperson Explanation

Why Has My Baby Got This?

Nappy rash is extremely common – almost all babies get it at some point. It's not because of poor hygiene or bad parenting.

The main cause is a chemical burn. When your baby's urine (pee) and poo mix together in the nappy, they create a chemical called ammonia (like household bleach). Because the skin is kept wet and rubbed by the nappy, this ammonia irritates and "burns" the top layer of skin.

How Can I Tell If It's Thrush (Yeast Infection)?

Look for these clues:

• The rash goes deep into the skin creases (groin folds)
• There are little red spots ("satellites") scattered around the edges
• The rash is bright, beefy red (more intense than regular nappy rash)
• Your baby might also have white patches in the mouth (oral thrush)

Thrush needs an antifungal cream – ask your pharmacist or doctor.

What Is the Best Treatment?

Fresh air is the single most powerful treatment. The nappy is like a greenhouse – warm and damp, which makes rashes worse.

What to do:

1. Leave the nappy off for 30 minutes, 2-3 times a day (put baby on a towel)
2. Change nappies frequently (every 2-3 hours)
3. Use barrier cream (Sudocrem, Metanium) – but apply it thinly (you should see skin through it)
4. Clean gently with water and cotton wool (avoid scented wipes if skin is broken)

When Should I See a Doctor?

Most nappy rashes clear up in 3-5 days. See your GP if:

• The rash is getting worse despite treatment
• Your baby has a fever
• The rash spreads outside the nappy area
• There are blisters, pus, or bleeding
• Your baby is very unsettled or refusing feeds
• The rash lasts more than 2 weeks

Can I Prevent Nappy Rash?

You can reduce the risk:

• Change nappies frequently (don't wait until they're very wet)
• Use high-absorbency disposable nappies
• Apply barrier cream as a protective layer at each change
• Give nappy-free time daily
• Introduce new foods gradually (sudden diet changes can cause diarrhoea)

---

13. Examination Focus

Common Exam Questions (MCQ/SBA)

Question 1: Clinical Diagnosis

Stem: A 10-month-old infant presents with an erythematous rash over the buttocks and perineum. The inguinal creases are not affected. What is the most likely diagnosis?

Options: A) Seborrhoeic dermatitis B) Candidal dermatitis C) Irritant contact dermatitis ✓ D) Atopic dermatitis E) Psoriasis

Answer: C – Flexural sparing is pathognomonic for ICD. [5]

---

Question 2: Candida Identification

Stem: Which feature most reliably distinguishes Candidal nappy rash from Irritant Contact Dermatitis?

Options: A) Presence of erythema B) Involvement of buttocks C) Satellite pustules ✓ D) Pain during nappy changes E) Resolution with barrier cream

Answer: C – Satellite pustules (1-3mm papulopustules peripheral to main rash) are pathognomonic for Candida. [15]

---

Question 3: Safety (Avoiding Harm)

Stem: A mother asks about using talcum powder for her infant's nappy rash. What is the main reason it should be avoided?

Options: A) Allergic contact dermatitis B) Inhalation pneumonitis ✓ C) Increased Candida growth D) Skin irritation E) Ineffective for rash

Answer: B – Talc inhalation causes chemical pneumonitis (serious respiratory complication). [19]

---

Question 4: Pathophysiology

Stem: What is the role of faecal urease in the pathogenesis of Irritant Contact Dermatitis?

Options: A) Directly digests keratin B) Produces proteolytic enzymes C) Converts urea to ammonia ✓ D) Increases skin pH E) Promotes bacterial overgrowth

Answer: C – Urease cleaves urinary urea → ammonia, raising pH and activating faecal proteases/lipases. [14]

---

Question 5: Red Flag Diagnosis

Stem: A 6-month-old infant has a severe, erosive periorificial rash unresponsive to barrier creams and antifungals. There is also alopecia and chronic diarrhoea. What is the most likely diagnosis?

Options: A) Severe Candida dermatitis B) Langerhans cell histiocytosis C) Acrodermatitis enteropathica ✓ D) Severe atopic dermatitis E) Congenital immunodeficiency

Answer: C – Classic triad: Periorificial dermatitis + alopecia + diarrhoea = zinc deficiency. [6]

---

Viva Voce Scenarios

Scenario 1: Basic Management

Examiner: "A mother brings her 8-month-old with a red rash on the buttocks. What questions would you ask?"

Model Answer: "I would take a focused history:

1. Onset and duration: Acute or chronic?
2. Distribution: Does it involve the skin creases?
3. Recent changes: New foods, antibiotics, illness, diarrhoea?
4. Nappy routine: Frequency of changes, type of nappies, cleansing method
5. Previous treatments tried: Barrier creams, antifungals?
6. Systemic features: Fever, feeding, oral lesions (thrush)?

On examination, I would assess for flexural sparing (ICD) vs involvement (Candida), and look for satellite pustules."

---

Scenario 2: Resistant Rash

Examiner: "A nappy rash has persisted for 6 weeks despite barrier creams and antifungals. What are your differentials?"

Model Answer: "For chronic, treatment-resistant nappy rash, I would consider:

Common:

• Candida with bacterial superinfection
• Seborrhoeic dermatitis
• Napkin psoriasis

Important 'Do Not Miss':

• Acrodermatitis enteropathica (zinc deficiency): Periorificial, erosive, with alopecia and diarrhoea
• Langerhans cell histiocytosis: Seborrhoeic-like with petechiae
• Cow's milk protein allergy: Chronic diarrhoea, failure to thrive

I would investigate with:

• Serum zinc and alkaline phosphatase
• Skin swabs (bacterial and fungal)
• Consider skin biopsy if unresponsive
• Refer to paediatric dermatology"

---

Scenario 3: Pharmacology

Examiner: "When would you prescribe topical corticosteroids for nappy rash, and which one?"

Model Answer: "Indications for topical corticosteroids:

• Severe inflammation causing significant discomfort
• Failed conservative measures (ABCDE protocol) after 5-7 days
• Not routine first-line treatment

I would prescribe:

• Hydrocortisone 1% only (mild potency, safe in infants)
• Apply thinly BD
• Maximum 7 days duration
• Application technique: Steroid first, wait 15 minutes, then barrier cream

Avoid:

• Potent steroids (risk of systemic absorption, skin atrophy, striae)
• Prolonged use (> 7-10 days)

If concurrent Candida suspected, use combination product (e.g., Daktacort: Miconazole + Hydrocortisone) for maximum 7 days."

---

Clinical Examination (OSCE Station)

Scenario: Examine this infant with a nappy rash and advise the mother on management.

Approach:

1. Introduction: Wash hands, introduce self, confirm infant identity, gain consent

2. Inspection:

   • Distribution: Convex surfaces vs flexures
   • Morphology: Erythema, maceration, erosions, pustules
   • Specific signs: Satellite pustules (Candida), flexural sparing (ICD)

3. Examine related areas:

   • Mouth: Oral thrush (white plaques on buccal mucosa)
   • Scalp: Cradle cap (seborrhoeic dermatitis)
   • Other flexures: Axillae, neck (seborrhoeic distribution)

4. Advise mother:

   • "This is irritant nappy rash [or Candida if appropriate], which is very common."
   • Explain ABCDE protocol (emphasize air exposure and frequent changes)
   • Demonstrate thin application of barrier cream
   • Safety-net: When to return (worsening, spreading, systemic features)

---

14. Related Topics

Prerequisites

• Neonatal Skin Barrier Development: Understanding stratum corneum maturation, TEWL, pH changes
• Contact Dermatitis (General): Irritant vs allergic mechanisms

Consequences

• Bacterial Skin Infections in Children: Impetigo, cellulitis, SSSS
• Cutaneous Candidiasis: Pathophysiology, antifungal resistance

Differentials

• Infantile Seborrhoeic Dermatitis: Cradle cap, flexural involvement, greasy scale
• Paediatric Psoriasis: Napkin psoriasis, Auspitz sign, family history
• Acrodermatitis Enteropathica: Zinc transporter defects, systemic features

Multi-Specialty Links

• Gastroenterology: Chronic diarrhoea, malabsorption, cow's milk protein allergy
• Immunology: Severe combined immunodeficiency (SCID), chronic granulomatous disease
• Genetics: Zinc transporter mutations (SLC39A4), epidermolysis bullosa

---

15. Key Takeaways (Summary Card)

---

16. References

Primary Sources

1. Klunk C, Domingues E, Wiss K. An update on diaper dermatitis. Clin Dermatol. 2014;32(4):477-487. doi:10.1016/j.clindermatol.2014.02.003

2. Blume-Peytavi U, Kanti V. Prevention and treatment of diaper dermatitis. Pediatr Dermatol. 2018;35 Suppl 1:s19-s23. doi:10.1111/pde.13495

3. Visscher MO, Chatterjee R, Munson KA, Bare DE, Hoath SB. Development of diaper rash in the newborn. Pediatr Dermatol. 2000;17(1):52-57. doi:10.1046/j.1525-1470.2000.01711.x

4. Davies MW, Dore AJ, Perissinotto KL. Topical vitamin A, or its derivatives, for treating and preventing napkin dermatitis in infants. Cochrane Database Syst Rev. 2005;(4):CD004300. doi:10.1002/14651858.CD004300.pub2

5. Berg RW. Etiologic factors in diaper dermatitis: the role of feces. Pediatr Dermatol. 1986;3(2):107-112. doi:10.1111/j.1525-1470.1986.tb00502.x

6. Maverakis E, Fung MA, Lynch PJ, et al. Acrodermatitis enteropathica and an overview of zinc metabolism. J Am Acad Dermatol. 2007;56(1):116-124. doi:10.1016/j.jaad.2006.08.015

7. Hoeger PH. Differential diagnosis of napkin dermatitis. Pediatr Dermatol. 2017;34 Suppl 1:s10-s14. doi:10.1111/pde.13150

8. Patrizi A, Neri I, Fiorentini C, Bonci A, Ricci G. Granuloma gluteale infantum with atypical features. Pediatr Dermatol. 1991;8(1):28-31. doi:10.1111/j.1525-1470.1991.tb00828.x

9. Wolf R, Wolf D, Tüzün B, Tüzün Y. Diaper dermatitis. Clin Dermatol. 2000;18(6):657-660. doi:10.1016/s0738-081x(00)00151-8

10. Ferrazzini G, Kaiser RR, Hirsig Cheng SK, et al. Microbiological aspects of diaper dermatitis. Dermatology. 2003;206(2):136-141. doi:10.1159/000068467

11. Warshaw EM, Ahmed RL, Belsito DV, et al. Contact dermatitis of the hands in children: retrospective analysis of North American Contact Dermatitis Group data, 1994-2004. J Am Acad Dermatol. 2007;57(5):820-827. doi:10.1016/j.jaad.2007.04.010

12. Stamatas GN, Nikolovski J, Luedtke MA, Kollias N, Wiegand BC. Infant skin microstructure assessed in vivo differs from adult skin in organization and at the cellular level. Pediatr Dermatol. 2010;27(2):125-131. doi:10.1111/j.1525-1470.2009.00973.x

13. Buckingham KW, Berg RW. Etiologic factors in diaper dermatitis: the role of urine. Pediatr Dermatol. 1986;3(2):102-106. doi:10.1111/j.1525-1470.1986.tb00501.x

14. Atherton DJ. A review of the pathophysiology, prevention and treatment of irritant diaper dermatitis. Curr Med Res Opin. 2004;20(5):645-649. doi:10.1185/030079904125003575

15. Hoeger PH, Enzmann CC. Skin physiology of the neonate and young infant: a prospective study of functional skin parameters during early infancy. Pediatr Dermatol. 2002;19(3):256-262. doi:10.1046/j.1525-1470.2002.00082.x

16. Ladhani S, Joannou CL, Lochrie DP, Evans RW, Poston SM. Clinical, microbial, and biochemical aspects of the exfoliative toxins causing staphylococcal scalded-skin syndrome. Clin Microbiol Rev. 1999;12(2):224-242. doi:10.1128/CMR.12.2.224

17. Andersen PH, Bucher AP, Saeed I, et al. Faecal enzymes: in vivo human skin irritation. Contact Dermatitis. 1994;30(3):152-158. doi:10.1111/j.1600-0536.1994.tb00565.x

18. Odio M, Friedlander SF. Diaper dermatitis and advances in diaper technology. Curr Opin Pediatr. 2000;12(4):342-346. doi:10.1097/00008480-200008000-00008

19. National Institute for Health and Care Excellence. Nappy rash. Clinical Knowledge Summaries. 2022. https://cks.nice.org.uk/topics/nappy-rash/

20. Association of Women's Health, Obstetric and Neonatal Nurses. Neonatal Skin Care: Evidence-Based Clinical Practice Guideline. 4th ed. AWHONN; 2018.

21. American Academy of Pediatrics. Caring for your baby's skin. HealthyChildren.org. Updated 2021. https://www.healthychildren.org/

---

Medical Disclaimer: MedVellum content is for educational purposes and clinical reference. Clinical decisions should account for individual patient circumstances. Always consult appropriate specialists and follow local guidelines.